Effect of Lenacapavir and PF74 on HIV-1 capsid morphology: EM images
Data files
Mar 18, 2025 version files 51.09 GB
-
EM_Raw_Images.xlsx
70.87 KB
-
Exp1_Stack1.tif
3.69 GB
-
Exp1_Stack2.tif
3.69 GB
-
Exp1_Stack3.tif
3.69 GB
-
Exp1_Stack4.tif
589.84 MB
-
Exp1_Stack5.tif
3.52 GB
-
Exp1_Stack6.tif
3.52 GB
-
Exp1_Stack7.tif
3.52 GB
-
Exp1_Stack8.tif
1.94 GB
-
Exp2_Stack1.tif
3.52 GB
-
Exp2_Stack2.tif
3.52 GB
-
Exp2_Stack3.tif
3.52 GB
-
Exp2_Stack4.tif
3.52 GB
-
Exp2_Stack5.tif
3.52 GB
-
Exp2_Stack6.tif
3.52 GB
-
Exp2_Stack7.tif
3.52 GB
-
Exp2_Stack8.tif
2.32 GB
-
README.md
962 B
Abstract
Lenacapavir (GS-6207; LEN) is a potent HIV-1 capsid inhibitor approved for treating multidrug-resistant infection. LEN binds to a hydrophobic pocket between neighboring capsid (CA) proteins in hexamers and stabilizes the capsid lattice, but its effect on HIV-1 capsids is not fully understood. Here, we labeled HIV-1 capsids with green fluorescent protein fused to CA (GFP-CA) or a fluid-phase GFP content marker (cmGFP) to assess LEN's impact on HIV-1 capsids. HIV-1 cores labeled with GFP-CA, but not cmGFP, could be immunostained with an anti-GFP antibody and were less sensitive to the capsid-binding host restriction factor MX2, demonstrating that GFP-CA is incorporated into the capsid lattice and is a marker for capsid lattice stability whereas cmGFP is an indicator of core integrity. LEN treatment of isolated HIV-1 cores resulted in a dose-dependent loss of cmGFP signal while preserving the GFP-CA signal, indicating that LEN disrupts core integrity but stabilizes the capsid lattice. In contrast, capsid inhibitor PF-3450074 (PF74) induced loss of core integrity and the capsid lattice. Electron microscopy of LEN- or PF74-treated viral cores revealed frequent breakage at the narrow end of the capsid and other morphological changes. Our results suggest that LEN treatment does not prevent nuclear envelope docking but inhibits nuclear import of cores with or without loss of core integrity. In contrast, PF74 treatment blocks nuclear import by inhibiting the nuclear envelope docking of viral cores, highlighting their different mechanisms of nuclear import inhibition.
https://doi.org/10.5061/dryad.70rxwdc7z
Description of the data and file structure
Images of HIV-1 capsids were captured using electron microscopy. The raw images, with identifying information removed, were organized into TIFF stacks. The file “EM_Raw_Images.xlsx” includes details such as the sample name, image stack name, image number, and capsid morphology for each detected capsid. In total, 1,819 capsids were analyzed from two experiments.
Files and variables
File: EM_Raw_Images.xlsx
Description: The TIFF stack name and image number for each analyzed HIV-1 capsid are provided here.
File: Exp#_Stack#.tif
Description: raw image stacks. See Excel file for metadata
Code/software
ImageJ can be used to view the images. ImageJ can be downloaded at: https://imagej.net/ij/
Negative stain electron microscopy. Mature cores (5 µL of fraction 19) were incubated with 5 µL HS+IP6 buffer containing LEN (1, 10, or 100 nM final concentration) or PF74 (10 µM final concentration) in a 0.2 mL PCR tube for 20 min at 37ºC. HIV core specimen (5 µL) was applied to carbon film coated 200 or 400 mesh copper grids (Electron Microscopy Sciences). Grids were rendered hydrophilic by glow discharge prior to usage. After a 1 min incubation, the unbound specimen was wicked off with Whatman filter paper and stained with 2 droplets of 2% uranyl acetate for 1 min. After wicking off excess stain, grids were air dried and examined using a Hitachi 7800 transmission electron microscope at 80kV and imaged using a 5056X2960 pixel CCD camera (NanoSprint 15B, Advanced Microscopy Techniques). The observed capsid morphologies were categorized into four types: apparently intact, broken at the narrow end, broken (other), and aberrant. Samples were blinded and the number and percentage of capsids in each category was determined for each sample condition.